Krystal Biotech, Inc. announced the appointment of Catherine Mazzacco to its Board of Directors. Mazzacco was Chief Executive Officer and President of LEO Pharma. Prior to this role, Ms. Mazzacco was Senior Vice President, Global Commercial Operations, Life Sciences Division at GE HealthCare.

Before joining GE HealthCare, Ms. Mazzacco spent over 25 years at Abbott Laboratories holding global senior operational and strategic leadership roles, including, most recently, Vice President, Global Commercial Operations, Abbott Vision Division. Ms. Mazzacco is a Member of the Supervisory Board and Remuneration & Nomination Committee of Servier. Ms. Mazzacco holds a BSE, Engineering, Option Biotechnology from the University of Compiègne in France.